One of my concerns is that AECL's commercial division and the division for isotopes, etc., worked hand in hand with a lot of institutional cooperation and compatibility. Are we now worried, or what kind of safeguards do we have to make sure that we're not losing institutional knowledge and expertise by separating entities that in the past leaned on each other quite significantly and worked together quite harmoniously?
On November 28th, 2011. See this statement in context.